Safety of sodium–glucose c <scp>otransporter</scp> 2 inhibitors in Asian type 2 diabetes populations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of sodium–glucose c otransporter 2 inhibitors in Asian type 2 diabetes populations

Published:2022-10-19 Issue:2 Volume:14 Page:167-182
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Davidson Jaime A¹,Sukor Norlela²^ORCID,Hew Fen‐Lee³,Mohamed Mafauzy⁴,Hussein Zanariah⁵

Affiliation:

1. Touchstone Diabetes Center The University of Texas Southwestern Medical Center Dallas Texas USA

2. Universiti Kebangsaan Malaysia Medical Centre Kuala Lumpur Malaysia

3. Subang Jaya Medical Centre Subang Jaya Selangor Malaysia

4. School of Medical Sciences Universiti Sains Malaysia Kelantan Malaysia

5. Putrajaya Hospital Putrajaya Malaysia

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13915

Reference134 articles.

1. Place of sodium-glucose cotransporter-2 inhibitors in East Asian subjects with type 2 diabetes mellitus: Insights into the management of Asian phenotype

2. Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response: A systematic review and meta-analysis

3. Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement

4. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review;Clinical Medicine Insights: Endocrinology and Diabetes;2024-01

2. Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations;Journal of Diabetes Investigation;2023-11-21

3. Application and Influence of Dapagliflozin in Patients with Type 2 Diabetes Mellitus;Medical Diagnosis;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3